These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 26398824)
61. A USE1ful Biomarker and Molecular Target in Lung Cancer? Xu W; Neckers L J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27770043 [No Abstract] [Full Text] [Related]
62. QnAs with Sangeeta N. Bhatia. Nair P Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1243-1245. PubMed ID: 31907307 [No Abstract] [Full Text] [Related]
63. Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40. Hayashi T; Takamochi K; Yanai Y; Mitani K; Tomita H; Mogushi K; Suehara Y; Takahashi F; Suzuki K; Saito T; Yao T Hum Pathol; 2018 Aug; 78():177-181. PubMed ID: 29410129 [TBL] [Abstract][Full Text] [Related]
64. The expression of YAP1 and other transcription factors contributes to lineage plasticity in combined small cell lung carcinoma. Jimbo N; Ohbayashi C; Fujii T; Takeda M; Mitsui S; Tanaka Y; Itoh T; Maniwa Y J Pathol Clin Res; 2024 Sep; 10(5):e70001. PubMed ID: 39283755 [TBL] [Abstract][Full Text] [Related]
65. Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature. Marando A; Zagni M; Negrelli M; Valtorta E; Lauricella C; Motta V; Veronese S; Cerea G; Giannetta LG; Ciarlo G; Signorelli D; Pizzutilo EG; Bonoldi E; Pelosi G Pathologica; 2024 Feb; 116(1):13-21. PubMed ID: 38482671 [TBL] [Abstract][Full Text] [Related]
66. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report. Terada K; Menju T; Date H; Haga H; Yoshizawa A Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955 [TBL] [Abstract][Full Text] [Related]
67. Lack of imbalance between the master regulators TTF1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer. Vescio M; Bulloni M; Pelosi G; Pattini L Sci Rep; 2024 Jan; 14(1):2467. PubMed ID: 38291083 [TBL] [Abstract][Full Text] [Related]
68. Liver X receptors and estrogen receptor β, two players in a rare subtype of NSCLC. Wu W; Sarhadi M; Song X; Xue J; Dai Y; Gustafsson JA Int J Biol Sci; 2023; 19(9):2848-2859. PubMed ID: 37324952 [TBL] [Abstract][Full Text] [Related]
69. P40 and TTF-1 double-expressing non-small cell lung cancer with EML4-ALK and PIK3CA gene mutations: A case report and review of the literature. Cai Y; Liu H; Chen X; Yang J; Huang B Oncol Lett; 2023 Feb; 25(2):59. PubMed ID: 36644157 [TBL] [Abstract][Full Text] [Related]
70. Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours. Savari O; Febres-Aldana C; Chang JC; Fanaroff RE; Ventura K; Bodd F; Paik P; Vundavalli M; Saqi A; Askin FB; Travis WD; Rekhtman N Histopathology; 2023 Jan; 82(2):242-253. PubMed ID: 36130728 [TBL] [Abstract][Full Text] [Related]
71. Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq. Li Q; Wang R; Yang Z; Li W; Yang J; Wang Z; Bai H; Cui Y; Tian Y; Wu Z; Guo Y; Xu J; Wen L; He J; Tang F; Wang J Genome Med; 2022 Aug; 14(1):87. PubMed ID: 35962452 [TBL] [Abstract][Full Text] [Related]
72. Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations. Pelosi G; Bulloni M; Vescio M; Uccella S; Forest F; Leone G; Barberis M; Rahal D; Bossi P; Finzi G; Marchiori D; De Luca M; Sessa F; Harari S; Spinelli M; Viola P; Macrì P; Maria S; Rizzo A; Picone A; Pattini L JTO Clin Res Rep; 2021 Nov; 2(11):100222. PubMed ID: 34746884 [TBL] [Abstract][Full Text] [Related]
73. TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit. Cabibi D; Bellavia S; Giannone AG; Barraco N; Cipolla C; Martorana A; Rodolico V; Cajozzo M; Florena AM Diagnostics (Basel); 2020 Jan; 10(1):. PubMed ID: 31935792 [TBL] [Abstract][Full Text] [Related]
74. When tumor doesn't read textbook. Third case of TTF1 and p40 co-expression in the same tumour cells in a non-small cell carcinoma. A potential new entity to consider? Spinelli M; Khorshad J; Viola P Pathologica; 2019 Jun; 111(2):58-61. PubMed ID: 31388196 [TBL] [Abstract][Full Text] [Related]
75. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. Yatabe Y; Dacic S; Borczuk AC; Warth A; Russell PA; Lantuejoul S; Beasley MB; Thunnissen E; Pelosi G; Rekhtman N; Bubendorf L; Mino-Kenudson M; Yoshida A; Geisinger KR; Noguchi M; Chirieac LR; Bolting J; Chung JH; Chou TY; Chen G; Poleri C; Lopez-Rios F; Papotti M; Sholl LM; Roden AC; Travis WD; Hirsch FR; Kerr KM; Tsao MS; Nicholson AG; Wistuba I; Moreira AL J Thorac Oncol; 2019 Mar; 14(3):377-407. PubMed ID: 30572031 [TBL] [Abstract][Full Text] [Related]
76. Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? Bernardi FDC; Bernardi MDC; Takagaki T; Siqueira SAC; Dolhnikoff M Clinics (Sao Paulo); 2018 Oct; 73():e361. PubMed ID: 30379223 [TBL] [Abstract][Full Text] [Related]
77. Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells. Pelosi G; Fabbri A; Tamborini E; Perrone F; Testi AM; Settanni G; Busico A; Centonze G; Braidotti P; Bulfamante G; De Braud F; Garassino M; Pastorino U J Thorac Oncol; 2015 Oct; 10(10):1500-2. PubMed ID: 26398824 [No Abstract] [Full Text] [Related]